Connect with us
European Gaming Congress 2024

Artificial Intelligence

Subang Jaya Medical Centre Applauded by Frost & Sullivan as the Best Hospital Company of the Year in Malaysia for the fourth consecutive year

Published

on

subang-jaya-medical-centre-applauded-by-frost-&-sullivan-as-the-best-hospital-company-of-the-year-in-malaysia-for-the-fourth-consecutive-year

SJMC’s significant efforts in alleviating nursing shortages, enhancing workflows and its strong market-leading position, both locally and globally resulted in high patient retention and strong referrals.
SAN ANTONIO, May 20, 2024 /PRNewswire/ — Frost & Sullivan recently analyzed the hospital industry and noted that operational inefficiencies, workflow interruptions and shortage of skilled healthcare professionals are some key challenges faced by the healthcare industry. Based on its findings, Subang Jaya Medical Centre (SJMC) is recognized with the 2024 Malaysian Best Hospital Company of the Year Award for the fourth consecutive year in the hospitals industry, making it the first to be recognized continuously with this prestigious accolades

The company is a private hospital with 443 licensed beds and over 150 outpatient clinics. It handles approximately 50,000 admissions and 550,000 outpatient visits annually. With a workforce of around 1,600 healthcare professionals, SJMC offers services across more than 260 medical specialties encompassing diverse therapeutic areas such as oncology, cardiology, orthopedics, digestive health as well as women and children health.
Bhaskar Vittal, industry principal at Frost & Sullivan, observed, “SJMC provides comprehensive and integrated care, implementing practices aimed at achieving the best possible outcomes for patients. A typical cancer patient journey at SJMC starts with awareness-building and screening programs, continuing with diagnosis, treatment, and aftercare, which includes support groups, educators, and counselors—all key elements in cancer care management.
SJMC is a finalist flagship medical tourism hospital selected by the Malaysian Healthcare Travel Council (MHTC) which is fully endorsed by the Malaysian Ministry of Health. It has achieved several accreditations including the Joint Commission International (JCI) Accreditation and aims at providing patients a seamless transition throughout their health journey in Malaysia. Patient onboarding follows a process-oriented approach from the inquiry level, where patients receive detailed information on available services, specialist doctors, and treatment availability.
SJMC has achieved international branding and recognition for its Cancer & Radiosurgery Centre (CRC), known for its person-centered care approach. Moreover, the hospital has been credited by the Australian Council on Healthcare Standards International (ACHSI) as the first Center of Excellence (CoE) for oncology services in Asia-Pacific, marking a milestone achievement. SJMC continuously improves patient treatment options, expands day care surgical offerings, and prioritizes safety, faster recovery, and lower costs in line with industry trends to achieve medical excellence.
The hospital’s Genetic Wellness, a first-of-its-kind clinical-grade genetics testing program, provides more than 1,000 insights into patients’ health conditions based on their unique genetic blueprint. The test provides individualized information on a wide range of conditions, including chronic, infectious, and metabolic diseases, allergies, and drug responses, allowing individuals to make informed choices for their overall wellbeing.
SJMC became the first hospital in Malaysia to introduce a remote patient monitoring system, SeniorConnect, that is tailored to the unique needs of senior patients and is particularly beneficial in urban settings, where it is common for working adults to face challenges in caring for their elderly relatives. It is also the first hospital in Malaysia to perform day care robotic-assisted total knee replacement and total hip replacement procedures using the Mako SmartRobotics system. It also focuses on preventive and precision healthcare—key trends in the global healthcare industry.
Its continuous glucose monitoring (CGM) technology allows diabetes patients to continuously monitor and control their blood glucose. SJMC also successfully conducted a clinical improvement project, titled “Reducing Early Morning In-Patient Hypoglycemia Incidence among In-Patient Adults with Type 2 Diabetes Mellitus in non-Critical Care Wards,” which found that patients adhering to the recommended snack regimen experienced zero hypoglycemic incidents. SJMC aims to enhance diabetes wellness with its multidisciplinary approach through revolutionary technology and in-depth research.
SJMC’s artificial intelligence (AI)-powered Radixact X9 with Synchrony synchronizes the movement of radiation beams with the tumor’s motion, allowing seamless and continuous radiation delivery during the patient’s natural breathing patterns. This technology enables delivering accurate radiation dosage while minimizing exposure to healthy tissues.
“SJMC’s digital technologies and equipment enhance the patient journey, improve clinical outcomes, and provide the healthcare workforce with the best tools to achieve their medical excellence goals,” added Vittal.
Bryan Lin, Chief Executive Officer of SJMC expressed his gratitude for receiving this prestigious recognition for the fourth time, saying, “We’re honored to be recognized for the exceptional care our dedicated staff provides. Their unwavering commitment and teamwork are what truly make a difference for our patients. We’ll continue to pursue excellence and deliver world-class healthcare.”
“In today’s healthcare landscape, strengthening the healthcare workforce, enhancing workflows, and solidifying our market-leading position are paramount. We’re committed to achieving these goals by empowering our staff through training which improves the quality of patient care and equipping them with tools that enhance decision-making while encouraging them to embrace and learn in this digital healthcare era,” he adds.
With its excellent financial performance, seamless customer experiences, and strong overall performance, Subang Jaya Medical Centre’s unwavering dedication to exceptional healthcare is again recognized on the international stage, with their fourth consecutive award win.
Each year, Frost & Sullivan presents a Company of the Year award to the organization that demonstrates excellence in terms of growth strategy and implementation in its field. The award recognizes a high degree of innovation with products and technologies, and the resulting leadership in terms of customer value and market penetration.
Frost & Sullivan Best Practices awards recognize companies in various regional and global markets for demonstrating outstanding achievement and superior performance in leadership, technological innovation, customer service, and strategic product development. Industry analysts compare market participants and measure performance through in-depth interviews, analyses, and extensive secondary research to identify best practices in the industry.
About Frost & SullivanFor six decades, Frost & Sullivan has been world-renowned for its role in helping investors, corporate leaders, and governments navigate economic changes and identify disruptive technologies, Mega Trends, new business models, and companies to action, resulting in a continuous flow of growth opportunities to drive future success. Contact us: Start the discussion.
Contact:Tarini SinghP: +91-9953764546E:[email protected]
About SJMC
Subang Jaya Medical Centre (SJMC)
SJMC has an impeccable reputation as one of Malaysia’s most trusted private medical centres best known for its clinical outcomes. The hospital is an award-winning 443-bed multi-disciplinary tertiary hospital of CAH Medical Centres (previously known as Ramsay Sime Darby Health Care Group), providing comprehensive and complex care in all specialties.
It is one of the few internationally accredited Joint Commission International (JCI) hospitals in Malaysia and Malaysian Society for Quality in Health (MSQH) accredited. SJMC’s laboratory is also an internationally recognized MS ISO 15189 accredited since 2009. In 2023, SJMC Oncology (Cancer) Services is certified by Australian Council of Healthcare Standards (ACHS) International as a Centre of Excellence, making it the first in Asia-Pacific.
SJMC is recognized as a finalist for the Flagship Medical Tourism Hospital Programme 2023 – 2025 by Malaysia Healthcare Travel Council (MHTC) to establish Malaysia as a globally renowned icon for healthcare travel, delivering exceptional end-to-end patient experiences anchored on medical excellence, service excellence, and international branding. It receives both local patients across Malaysia and international patients across the Asia Pacific with over 47,000 admissions and almost half a million outpatient visits annually.
For more information, contact:Celia TanP: +60 17 930 8200E: [email protected] 
Nur Yee Jie MinP: +012 355 1885E: [email protected] 
Photo – https://mma.prnewswire.com/media/2415752/SJMC_Award.jpg

View original content:https://www.prnewswire.co.uk/news-releases/subang-jaya-medical-centre-applauded-by-frost–sullivan-as-the-best-hospital-company-of-the-year-in-malaysia-for-the-fourth-consecutive-year-302148854.html

Continue Reading
Advertisement
Stake.com

Artificial Intelligence

APIX and RBI Join Forces to Drive Financial Innovation Through HaRBInger 2024 Hackathon

Published

on

apix-and-rbi-join-forces-to-drive-financial-innovation-through-harbinger-2024-hackathon

SINGAPORE, June 21, 2024 /PRNewswire/ — APIX, the leading global collaborative innovation platform for financial institutions and fintechs across over 90 countries, today announced its partnership with the Reserve Bank of India (RBI) to host the prestigious HaRBInger 2024 hackathon. This landmark collaboration aims to bring together the brightest minds from around the world to develop cutting-edge solutions that enhance the security and inclusivity of the financial ecosystem.

Under the overarching themes of Combatting Fraud and Financial Inclusion for the Differently-abled, the hackathon challenges participants to tackle four critical problem statements focused on real-time fraud detection, ensuring transaction anonymity, identifying mule accounts, and empowering the visually impaired in financial transactions.
“At APIX Platform, we are thrilled and proud to once again partner with Reserve Bank of India (RBI) for HaRBInger,” shares Umang Moondra, CEO of APIX. “Reserve Bank of India (RBI) has led from the front in driving innovation in the financial services sector, and HaBRInger 2024’s focus on critical challenges related to fostering security, integrity, transparency, trust and inclusivity in digital transactions, is a testament to the leadership role that they play.”
As a trusted platform utilised by major banks and regulators worldwide, APIX is uniquely positioned to empower innovators and accelerate their journey toward bringing innovative ideas to life. Leveraging innovative technologies such as AI/ML, APIs, Data Analytics, and more, HaRBInger 2024 participants will have the opportunity to create solutions that drive meaningful change and leave a lasting impact on the financial services industry.
The hackathon welcomes individuals, teams, and enterprises from diverse backgrounds and geographies to participate, offering a platform to showcase their skills on a global stage. With exciting prizes up for grabs, including INR 40,00,000 (~USD 48,000) for the winner in each problem statement category and a special prize of INR 20,00,000 (~USD 24,000) for the best all-woman team, the opportunities are substantial.
Registration for HaRBInger 2024 started on June 7, 2024, and will unfold in four exciting phases on the APIX Platform: screening of entries, shortlisting for solution development, solution development with mentoring and support, and the selection of winners.
Don’t miss this opportunity to collaborate with like-minded innovators, gain exposure to industry leaders, and shape the future of finance on the APIX Platform.
For media inquiries or additional details about HaRBInger 2024, please contact [email protected].
For more information and to register now, visit HaRBInger 2024 at: https://hackolosseum.apixplatform.com/h1/harbinger2024
About APIX:
APIX is a collaborative innovation platform for fintechs and innovators across 90+ countries, empowering Financial Institutions to accelerate their innovation journey. 
Major banks, insurers, and regulators in the world use APIX to rapidly discover, test, and evaluate solutions by running comprehensive innovation programs, which include innovation challenges and hackathons. 
Ideas are everywhere. Bring the best to the table with APIX. Collaborate to innovate today at www.apixplatform.com.  
Logo – https://mma.prnewswire.com/media/2443613/4773081/01_LOGO_COLOR_WITH_BLACK__MAIN_Logo.jpg

View original content:https://www.prnewswire.co.uk/news-releases/apix-and-rbi-join-forces-to-drive-financial-innovation-through-harbinger-2024-hackathon-302178678.html

Continue Reading

Artificial Intelligence

Maxterial Raises nearly $8 Million in Series A Funding

Published

on

maxterial-raises-nearly-$8-million-in-series-a-funding

Reinforces Position as a Disruptive Force in Material Science Innovation

PLEASANTON, Calif., June 20, 2024 /PRNewswire/ — Maxterial, a technology company dedicated to pioneering advancements in material science including the commercialization of advanced coatings, has announced the successful closure of its Series A funding round, raising nearly $8 million. This milestone underscores Maxterial’s rising influence in disruptive material science technologies and its commitment to reshaping traditional industry norms with dynamic and environmentally responsible solutions.
Led by CEO Dr. Mehdi Kargar and Chief Technology Officer Dr. Amy Haghdoost, Maxterial has pioneered material science advancements for nearly a decade. The company’s lean approach to reaching the product-growth fit stage has garnered widespread acclaim, attracting a range of customers and influential investors, including Peter Thiel’s Breakout Labs, Pierre Omidyar’s UP2398, and corporate innovation leaders like Saint-Gobain and Anglo American.
The Series A funding round, led by Helios Climate Ventures, with participation from global corporation QEMETICA (formerly Ciech), solidifies Maxterial’s position as a leader in climate-conscious innovation. This capital enables Maxterial to accelerate its R&D efforts, including large-scale trials, expand its products, and scale operations in North America and Europe.
“We are thrilled to have secured nearly $11 million to date in equity financing, which reflects the confidence investors have in our vision, our unique go-to-market strategies, and the transformative potential of our technology,” said Dr. Mehdi Kargar, CEO of Maxterial. “This scalable platform fits many markets in urgent need of dynamic, sustainable solutions. Series A funding enables us to drive transformational growth across multiple industries.”
Maxterial replaces environmentally harmful and energy-inefficient processes using Hexavalent Hard Chrome (H-Chrome) with a superior solution that is safe, environmentally friendly, and cost effective at a time when material science startups have struggled to attract investment. The company breaks those cycles by delivering unique synergies that integrate the needs of investors, customers, supply chains, and industry experts with a product and service model that delivers exceptional performance, accelerates change and mitigates risk.
Maxterial has already gained significant initial traction. Ongoing trials in Europe and North America are attracting early adopters eager for cutting-edge solutions. By prioritizing sustainability, performance, and scalability, Maxterial can protect against wear, heat, and corrosion, reduce carbon footprint, and eliminate toxic materials like hexavalent chromium.
“We set out to create a company that delivers exceptional technology and exceptional returns,” notes Dr. Kargar. “As we accelerate our implementation, we want to share our insights and expertise with fellow entrepreneurs, industry leaders, and investors interested in driving positive change.”
For media inquiries, please contact:
Carmen FerrignoChief Marketing Officer, MaxterialPhone: 215.287.3658Email: [email protected]
About Maxterial:Maxterial is a Bay Area technology company dedicated to pioneering advancements in material science, including the commercialization of advanced coatings. Founded in 2015, Maxterial leverages an eco-systemic lean tech approach to develop innovative solutions that protect against wear, heat, and corrosion while reducing carbon footprint and eliminating toxic materials from industrial processes. Maxterial is committed to driving responsible transformation in the material science industry through thought leadership, innovation, and collaboration that inspires others to embrace responsible innovation.
To learn more, visit Maxterial.com
Logo – https://mma.prnewswire.com/media/2440672/Maxterial__Logo.jpg 

View original content:https://www.prnewswire.co.uk/news-releases/maxterial-raises-nearly-8-million-in-series-a-funding-302177099.html

Continue Reading

Artificial Intelligence

Altair Named a Leader in the June 2024 Gartner® Magic Quadrant™ for Data Science and Machine Learning Platforms

Published

on

altair-named-a-leader-in-the-june-2024-gartner-magic-quadrant™-for-data-science-and-machine-learning-platforms

Altair recognized in the report’s Leaders’ Quadrant for Completeness of Vision and Ability to Execute
TROY, Mich., June 20, 2024 /PRNewswire/ — Altair (Nasdaq: ALTR), a global leader in computational intelligence, today announced that it has been positioned by Gartner as a Leader in the Magic Quadrant for Data Science and Machine Learning Platforms for its offering, Altair® RapidMiner®. The evaluation was based on specific criteria that analyzed the company’s overall Completeness of Vision and Ability to Execute.

According to the report, “Leaders in this market have a mature, refined, and targeted company and platform strategy that incorporates and leverages generative AI (GenAI) to drive their customers’ business value. They see opportunities for leveraging GenAI that other providers may not see or have made significant investments above and beyond standard offerings. They have the capability to innovate at a speed that outperforms other vendors. In addition, they can clearly articulate how they provide value to the multiple types of personas involved in the process of building data science and machine learning models.” 
“We believe being named as a Leader in this latest report validates what we have known for years: Altair has one of the market’s most unique, most comprehensive offerings for data analytics and machine learning,” said James R. Scapa, founder and chief executive officer, Altair. “For us, this placement is also a testament to our unmatched vision, which has defined us since our inception. We are pioneers that define what it means to be at the forefront of technological innovation and computational intelligence. I am incredibly proud of where Altair stands today, and I look forward to the strides we continue to make each day.”
Magic Quadrant reports are a culmination of rigorous, fact-based research in specific markets, providing a wide-angle view of the relative positions of the providers in markets where growth is high and provider differentiation is distinct. Providers are positioned into four quadrants: Leaders, Challengers, Visionaries and Niche Players. The research enables you to get the most from market analysis in alignment with your unique business and technology needs.
View a complimentary copy of the Magic Quadrant report to learn more about Altair’s strengths and cautions, among other provider offerings, at https://web.altair.com/gartner-magic-quadrant-for-data-science-and-machine-learning-platforms-2024.
Gartner Disclaimer
Gartner, Magic Quadrant for Data Science and Machine Learning Platforms, Afraz Jaffri, Aura Popa, Peter Krensky, Jim Hare, Raghvender Bhati, Maryam Hassanlou, Tong Zhang, 17 June 2024.
GARTNER is a registered trademark and service mark of Gartner, Inc. and/or its affiliates in the U.S. and internationally, and MAGIC QUADRANT is a registered trademark of Gartner, Inc. and/or its affiliates and are used herein with permission. All rights reserved.
Gartner does not endorse any vendor, product or service depicted in our research publications, and does not advise technology users to select only those vendors with the highest ratings or other designation. Gartner research publications consist of the opinions of Gartner research organization and should not be construed as statements of fact. Gartner disclaims all warranties, expressed or implied, with respect to this research, including any warranties of merchantability or fitness for a particular purpose.
About Altair
Altair is a global leader in computational intelligence that provides software and cloud solutions in simulation, high-performance computing (HPC), data analytics, and AI. Altair enables organizations across all industries to compete more effectively and drive smarter decisions in an increasingly connected world – all while creating a greener, more sustainable future. To learn more, please visit www.altair.com.
Media contacts
Altair Corporate                                           
Altair Investor Relations
Bridget Hagan                                             
Stephen Palmtag
+1.216.769.2658                                         
+1.669.328.9111
[email protected]                       
[email protected]
Altair Europe/The Middle East/Africa
Charlotte Hartmann
+49 7031 6208 0
[email protected]
 
Photo – https://mma.prnewswire.com/media/2444041/Altair_Newsroom_NR_Gartner_MQ_Social__2.jpg
Logo – https://mma.prnewswire.com/media/1421069/Altair_Logo.jpg

View original content:https://www.prnewswire.co.uk/news-releases/altair-named-a-leader-in-the-june-2024-gartner-magic-quadrant-for-data-science-and-machine-learning-platforms-302178198.html

Continue Reading

Trending